Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is as safe for the heart as finasteride.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Low-dose oral minoxidil is as effective as or better than topical minoxidil for hair growth but may cause mild side effects.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Anabolic steroids harm the heart, liver, hormones, muscles, and mental health.

Women with PCOS have a higher risk of heart disease.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.